Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Medical Oncology (Northwood, London, England)|June 25, 2014
Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?Alfredo Tartarone, Rosa Lerose, Chiara Lazzari, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 8, 2013
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF exampleAngelo Corti, Flavio Curnis, Gilda Rossoni, et al.
Journal of Thoracic Disease|July 10, 2020
Mechanisms of resistance to osimertinibChiara Lazzari, Vanesa Gregorc, Niki Karachaliou, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 5, 2024
Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancerChiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational Lung Cancer Research|June 24, 2021
Lung cancer screening: who pays? Who receives? The European perspectivesPierluigi Novellis, Silvia Raimondi Cominesi, Francesca Rossetti, et al.
International Journal of Molecular Sciences|September 4, 2020
Targeted Therapies in Early Stage NSCLC: Hype or Hope?Alex Friedlaender, Alfredo Addeo, Alessandro Russo, et al.
Expert Opinion on Investigational Drugs|July 10, 2020
New immunotherapeutic drugs in advanced non-small cell lung cancer (NSCLC): from preclinical to phase I clinical trialsDanilo Rocco, Vanesa Gregorc, Luigi Della Gravara, et al.
Current Opinion in Oncology|November 23, 2021
Angiogenesis inhibition in lung cancer: emerging novel strategiesChiara Lazzari, Alessandra Bulotta, Giuseppe Damiano, et al.
The Annals of Thoracic Surgery|June 10, 2021
Venoarterial Extracorporeal Membrane Oxygenation Support in Lung Cancer ResectionPierluigi Novellis, Fabrizio Monaco, Giovanni Landoni, et al.
Pageof 10